Bagsican, Jebril Raed .

HRN: 22-94-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
CEFTRIAXONE 1G (VIAL)
09/18/2023
09/25/2023
IV
700mg
Q24h
Pcap D
Waiting Final Action 
09/18/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
09/18/2023
09/24/2023
TOPICAL
-
Q12
T/C Bacterial Conjunctivitis
Waiting Final Action 
09/21/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/21/2023
09/27/2023
IV
700mg
Q8
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: